Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACL IN CABG – Atorvastatin dose regimens in cardiac surgery
2006-005757-30Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atorvastatin in coronary arteriosclerosis and cardiac ischemia (2 arms), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Primary endpoints: Postoperative inflammatory response and Early mortality (30 days). Started Jun 2007; status: active.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosiscardiac ischemia
Beyond the preview
Go deeper on 2006-005757-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005757-30.